Recursion Pharmaceuticals, Inc. - Class A Common Stock
Recursion Pharmaceuticals, Inc. - Class A Common Stock
Action · US75629V1044 · RXRX (XNAS)
Aperçu Indicateurs financiers
5,57 USD
23,23 % 1,05 USD
NASDAQ (XNAS) · Cours et graphiques actuels sur MoneyPeak
06.06.2025 23:59

Cours actuels de Recursion Pharmaceuticals, Inc. - Class A Common Stock

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
RXRX
USD
06.06.2025 23:59
5,57 USD
4,56 USD
+22,14 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
0,00 % 32,62 % 33,25 % -15,48 % -30,38 % -34,55 % -69,06 %

Profil de l'entreprise pour Recursion Pharmaceuticals, Inc. - Class A Common Stock Action

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 to treat familial adenomatous polyposis; and REC-3599, which is in Phase I clinical trial to treat GM2 gangliosidosis. Its preclinical stage product includes REC-3964 to treat Clostridium difficile colitis; REC-64917 for the treat of neural or systemic inflammation; REC-65029 to treat HRD-negative ovarian cancer; REC-648918 to enhance anti-tumor immune; REC-2029 for the treatment of wnt-mutant hepatocellular carcinoma; REC-14221 to treat solid and hematological malignancies; and REC-64151 for the treatment of immune checkpoint resistance in KRAS/STK11 mutant non-small cell lung cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Données de l'entreprise

Nom Recursion Pharmaceuticals, Inc. - Class A Common Stock
Société Recursion Pharmaceuticals, Inc.
Symbole RXRX
Site web https://www.recursion.com
Marché d'origine XNAS NASDAQ
ISIN US75629V1044
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Dr. Christopher C. Gibson Ph.D.
Capitalisation boursière 2 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 0,8 T
Adresse 41 South Rio Grande Street, 84101 Salt Lake City
Date d'introduction en bourse 2021-04-16

Symboles boursiers

Nom Symbole
NASDAQ RXRX

Autres actions

Les investisseurs qui détiennent Recursion Pharmaceuticals, Inc. - Class A Common Stock ont également les actions suivantes dans leur portefeuille :
FINLD 16-26
FINLD 16-26 Obligation
HELIUS MEDICAL TECHNOLOG.
HELIUS MEDICAL TECHNOLOG. Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025